AKT1 and Insulin resistance: Conversely, recombinant SPARC treatment of adipocytes reduced AKT phosphorylation (Figure 6F), which is consistent with a prior report that SPARC overexpression induced insulin-resistance in the 3T3L1 adipocyte cell line (38).